Vormittag, L <br/><br/>
Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Mar 2012 
 - 235-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1439-099X 
<br/><br/><label>Standard No.: </label>10.1007/s00066-011-0040-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Capecitabine<br/>Carcinoma, Squamous Cell--drug therapy<br/>Combined Modality Therapy--adverse effects<br/>Deoxycytidine--analogs & derivatives<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Mucositis--etiology<br/>Neoplasm Recurrence, Local--drug therapy<br/>Radiotherapy--adverse effects<br/>Squamous Cell Carcinoma of Head and Neck<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult